Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study

Complete list of metadatas

https://hal.univ-brest.fr/hal-02050833
Contributor : Ghislaine Calvez <>
Submitted on : Wednesday, February 27, 2019 - 1:58:40 PM
Last modification on : Friday, October 11, 2019 - 8:22:24 PM

Links full text

Identifiers

Citation

Delphine Rea, Franck Nicolini, Michel Tulliez, François Guilhot, Joëlle Guilhot, et al.. Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study. Blood, American Society of Hematology, 2017, 129 (7), pp.846-854. ⟨10.1182/blood-2016-09-742205⟩. ⟨hal-02050833⟩

Share

Metrics

Record views

139